Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Hashem El‐Serag being referenced
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Hashem El‐Serag | 27 | 95 | 34 | 122 | 95 | 4 | 278 | |
| Mohamed Ramdani | 48 | 26 | 51 | 121 | 66 | 10 | 295 | |
| Kathryn D’Addeo | 49 | 174 | 40 | 63 | 241 | 9 | 334 | |
| Meg O’Brien | 31 | 134 | 35 | 191 | 23 | 4 | 332 | |
| E O'Sullivan | 27 | 49 | 45 | 188 | 27 | 6 | 308 | |
| Rashid Ramezani | 29 | 73 | 16 | 137 | 22 | 12 | 300 | |
| Marion C. Olek | 42 | 59 | 5 | 186 | 87 | 5 | 323 | |
| S. H. M. Zaidi | 65 | 58 | 30 | 138 | 16 | 10 | 325 | |
| Elizabeth Hodgkinson | 36 | 22 | 48 | 199 | 48 | 10 | 296 | |
| Nina Cavalli‐Björkman | 57 | 21 | 47 | 230 | 32 | 9 | 303 | |
| Elaine Wong | 50 | 91 | 23 | 58 | 69 | 5 | 309 |
All Works
Loading papers...